Change Reflects Updated Strategy to Bring Entrepreneurial and Institutional-Quality Investment Opportunities to Accredited Investors
NEW YORK CITY – January 8, 2008 – Diversified Biotech Holdings Corp. has changed its name to Diversified Private Equity Corp (DPEC Partners). DPEC, to be known as DPEC Partners, is an integrated company whose businesses bring entrepreneurial, private equity and institutional-quality investments to accredited individual investors.
“Since 1999, we’ve been committed to giving qualified individual investors access to private-equity style investments otherwise unavailable to them. Since our scope now extends beyond opportunities in the biotech sector, we thought it would be appropriate to give the company a more accurate name,” said Scott Mathis, founder and chairman of DPEC Partners.
InvestBio, Inc. remains a key DPEC Partners subsidiary. It focuses on identifying and forming investment vehicles that enable selected accredited investors to participate in private equity investments in promising biotech companies. InvestBio investments have included The Vaccine Company, AmpliMed Corp, Kinexis, Inc. and others.
Executives of DPEC Partners have recently formed InvestProperty Group, LLC. This company currently develops real estate investing investment opportunities in Argentina for accredited individual investors. InvestProperty Group has already established opportunities in Argentina, including a luxury boutique hotel it is developing in the Recoleta neighborhood of Buenos Aires called the Algodon Mansion. The company has also purchased and is developing the Algodon Wine Estates in San Rafael, Mendoza, Argentina. It includes a winery and wine business, lodge, an award-winning restaurant, golf course, tennis complex, polo fields and homesites. Algodon is a luxury brand that InvestProperty created for its Argentine properties and opportunities.
Said Mr. Mathis, “InvestProperty’s near- and medium-term focus is Argentina. Through InvestProperty, the company’s U.S. investors can hedge the U.S. property market and invest almost directly in individual properties in a discounted but emerging market.”
Qualified investors participate in the biotech and property investments via DPEC’s wholly owned registered broker-dealer, DPEC Capital, a FINRA member firm. DPEC Capital focuses principally on opportunities created by InvestBio, Inc. and InvestProperty Group, LLC.
For more information, please contact Alexandra Corriveau at Sommerfield Communications, Inc. at 212-255-8386 or email@example.com.